Data as of Mar 14
| -0.55 / -1.15%|
The 9 analysts offering 12-month price forecasts for Integra LifeSciences Holdings Corp have a median target of 50.00, with a high estimate of 59.00 and a low estimate of 43.00. The median estimate represents a +6.07% increase from the last price of 47.14.
The current consensus among 16 polled investment analysts is to Hold stock in Integra LifeSciences Holdings Corp. This rating has held steady since March, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.